| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/11/2006 | CN1718193A Total secondary ginseng glucoside medicine composition, its prepn. method and application in preparing medicine for treating myocardial ischemia and hemorrhagic shock |
| 01/11/2006 | CN1718192A Powder injection of american ginseng glycol saponin, and its prepn. method |
| 01/11/2006 | CN1718191A Total secondary ginseng glucoside oral disintegration tablets prepn. method and application thereof |
| 01/11/2006 | CN1718190A Nux vomica alkaloid liposome, and its prepn. method |
| 01/11/2006 | CN1718187A Indapamide dripping pills, and its prepn. method |
| 01/11/2006 | CN1236057C Recombinant gland related virus expressing human kallikrein, its preparation method and application |
| 01/11/2006 | CN1236031C Novel production method of naphtha of rhizome of chuanxiong |
| 01/11/2006 | CN1235914C Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/11/2006 | CN1235877C Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 01/11/2006 | CN1235875C Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof |
| 01/11/2006 | CN1235638C Activated protein C formulations |
| 01/11/2006 | CN1235637C Methods for treating diabetes |
| 01/11/2006 | CN1235620C Medicine for treating cerebral thrombosis and its preparing process |
| 01/11/2006 | CN1235615C Chinese medicinal preparation for treating coronary heart disease, cerebral thrombus and cerebral infarct and preparing process thereof |
| 01/11/2006 | CN1235611C Chinese medicinal composition for treating hypertension, preparing process and use |
| 01/11/2006 | CN1235595C Chitin soft capsule and preparing method thereof |
| 01/11/2006 | CN1235589C Use of type 4 phosphodiesterase inhibitors in myocardial diseases |
| 01/11/2006 | CN1235583C Benzimidazole derivatives as therapeutic agents |
| 01/11/2006 | CN1235579C Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/11/2006 | CN1235576C Slow-released dosage form of sodium ferulate and preparation process thereof |
| 01/11/2006 | CN1235567C Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 01/11/2006 | CN1235566C Drondearone pharmaceutical composition for external gastrointestinal-tract administration |
| 01/10/2006 | US6984660 To treat and/or prevent hypertension, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, and endothelial dysfunction or endothelial damage as a consequence of atherosclerotic processes or diabetes |
| 01/10/2006 | US6984653 useful as a growth factor receptor tyrosine kinase HER2 (Human epidermal growth factor receptor-2) inhibitor; for treating cancer |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984650 Comprises phosphorescence and fluorescence resonance energy transfer; binding chenodeoxycholic acid to farnesoid X receptors; for regulating cholesterol absorption; for treatment of obesity |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984642 for treating cardiovascular disorders, for example for the acute and chronic treatment of ischaemic disorders |
| 01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
| 01/10/2006 | US6984636 Mitochondrially targeted antioxidants |
| 01/10/2006 | US6984621 Wound contraction inhibitor |
| 01/10/2006 | US6984402 Chrono delivery formulations and method of treating atrial fibrillation |
| 01/10/2006 | US6984397 Encapsulated pipecolic acid; immunosuppressants |
| 01/10/2006 | US6983749 Inducing hypothermia and rewarming using a helium-oxygen mixture |
| 01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 01/10/2006 | CA2425841C Angiostatic steroids |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/10/2006 | CA2381513C Bicyclic-substituted 4-amino-pyridopyrimidine derivatives |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/10/2006 | CA2364906C 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/10/2006 | CA2327758C (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/10/2006 | CA2299760C Cyano containing oxamic acids and derivatives as thyroid receptor ligands |
| 01/10/2006 | CA2298549C Combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night |
| 01/10/2006 | CA2262252C Method of treating heart failure |
| 01/10/2006 | CA2129897C Coa-it and paf inhibitors |
| 01/05/2006 | WO2006000137A1 Oral disintegrable tablet of notogingseng total sapoin and the preparation process thereof |
| 01/05/2006 | WO2006000007A1 Use of peptides derived from the a alpha or b beta chain of human fibrinogen for the treatment of shock |
| 01/05/2006 | WO2003016493A3 Transporters and ion channels |
| 01/05/2006 | US20060004207 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods |
| 01/05/2006 | US20060004084 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 01/05/2006 | US20060004080 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 01/05/2006 | US20060004078 N-hydroxyformamidine derivatives |
| 01/05/2006 | US20060004073 Compounds, compositions, and methods |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004056 Di-aryl-substituted-ethan pyridone pde4 inhibitors |
| 01/05/2006 | US20060004054 Administering 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline before or at the time angioplasty, coronary by-pass grafting or stent implantation |
| 01/05/2006 | US20060004051 Compounds |
| 01/05/2006 | US20060004033 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 01/05/2006 | US20060004030 Asthma, antiallergens; rheumatoid arthritis and atherosclerosis; anticarcinogenic agents; 2-(Benzylthio)-6-{[(1R)-2-hydroxy-1-methylethyl]amino}-4-pyrimidinol |
| 01/05/2006 | US20060004029 Nitrogen-containing aromatic derivatives |
| 01/05/2006 | US20060004028 Novel PARP inhibitor |
| 01/05/2006 | US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
| 01/05/2006 | US20060003992 New drug combinations |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003978 beta-secretase inhibitors; to reduce A beta peptide formation; to reduce amyloid beta deposits or plaques; 12-[2-(3-Ethyl-benzylamino)-1-hydroxy-ethyl]-16-fluoro-2-oxa-8,11-diaza-bicyclo[12.3.1]octadeca-1(17),14(18),15-triene-7,10-dione |
| 01/05/2006 | US20060003975 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor |
| 01/05/2006 | US20060003937 Urocortin-III and uses thereof |
| 01/05/2006 | US20060003932 Method for promoting neovascularization |
| 01/05/2006 | US20060003928 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 01/05/2006 | US20060003922 Spinner preparation machine and cavity resonator |
| 01/05/2006 | US20060003915 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 01/05/2006 | US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders |
| 01/05/2006 | US20060003379 Smad6 and uses thereof |
| 01/05/2006 | US20060003063 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 01/05/2006 | US20060002991 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 01/05/2006 | US20060002937 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 01/05/2006 | US20060002901 Composition containing eosinophil cationic protein |
| 01/05/2006 | US20060002898 Methods and compositions for correction of cardiac conduction disturbances |
| 01/05/2006 | US20060002893 Targeted adenovirus vectors for delivery of heterologous genes |
| 01/05/2006 | DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN |
| 01/05/2006 | DE102004028973A1 Substituierte Tetrahydro-2H-isochinolin-1-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted tetrahydro-2H-isoquinolin-1-one derivatives, to processes for their preparation and their use as a medicament |
| 01/05/2006 | DE102004026532A1 Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung Substituted oxazole Benzoisothiazoldioxidderivate, processes for their preparation and their use |
| 01/05/2006 | CA2584493A1 Kinase inhibitors for treating cancers |
| 01/05/2006 | CA2579716A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists |
| 01/05/2006 | CA2571990A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides |
| 01/05/2006 | CA2571447A1 Composition and method for treatment and prevention of atherosclerosis |
| 01/05/2006 | CA2570989A1 Product of vegetal origin comprising proanthocyanidines and its preparation process |
| 01/05/2006 | CA2570673A1 Compounds and methods for treating dyslipidemia |
| 01/05/2006 | CA2570615A1 Drugs for treating duplication of hypertension with hyperuricemia and /or hypercholesterolemia |
| 01/05/2006 | CA2569919A1 Oral sustained release formulation of tedisamil with gastric retention properties |
| 01/05/2006 | CA2544676A1 Use of peptides derived from the a alpha or b beta chain of human fibrinogen for the treatment of shock |
| 01/04/2006 | EP1612273A1 Novel physiologically active substances pf1270a, b and c |
| 01/04/2006 | EP1612268A1 Receptor ligand VEGF-C |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1612215A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/04/2006 | EP1611899A1 Combined use of g-csf with angiogenetic factor |